Delivery Order SPE2DB22D3010-SPE2DB25FP3CW
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,706.98 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.02 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.42 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.88 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector supplies. This non-set-aside, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used in the treatment of hormone deficiency, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,403.64 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector vials on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product, reflecting the company's role in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 mL auto-injector supplies, valued at $1,855.16, with a completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used to treat hypogonadism in male patients, and this order represents a...
- The Defense Logistics Agency awarded a $1,253.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units. The contract, issued on September 19, 2025, with completion targeted for September 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). This IDC, valued at $999.999 billion through December 2026, serves as a comprehensive global pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.98 to AmerisourceBergen Drug Corp for XYOSTED 50 MG/0.5 ML auto-injector units on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via...
- The Defense Logistics Agency awarded a $1,760.63 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for XYOSTED 75 mg/0.5 ml auto-injector supplies. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of May 22, 2025. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector, supporting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $5,138.67 to AmerisourceBergen Drug Corp for XYOSTED 50 MG/0.5 ML auto-injector supplies on July 14, 2025, with completion scheduled for July 15, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used to treat hypogonadism in males, and this order...